Optimizing Urate-Lowering Therapy in Gout Patients
|
|
Clinicians often reduce or discontinue urate-lowering therapy for gout patients if their kidney function declines, complicating management of the condition. A new study looked at whether urate-lowering therapy actually worsened kidney disease and found that achieving specific serum urate levels with urate-lowering therapy was well tolerated in patients with gout and stage 3 chronic kidney disease. Read more.
|
|
Lowering Men’s CVD Risks Earlier May Affect Cognitive Decline
|
|
At some point, many men with cardiovascular risk factors, including obesity, are urged to seek treatment. A new United Kingdom study suggests that it should occur sooner and not later. Why? Because males with cardiovascular disease (CVD) face brain-health declines a decade earlier than similarly situated women, according to the researchers. Learn more about the results of this study.
|
Gabapentinoid Use Linked to Increased Hip Fracture Risk
|
|
Gabapentinoids, such as pregabalin or gabapentin, became especially popular in the United States and elsewhere when they were prescribed as an alternative to burgeoning opioid usage a decade ago. In recent years, they have become widely prescribed to older adults. Find out why that is a problem, and which particular patients are at the highest risk of hip fractures.
|
|
Patient Education and Support for Blood Cancer
|
|
While medical treatment is an integral component of care for patients with blood cancer, effective care is multifaceted and warrants a multidisciplinary approach. Patients with blood cancer may also require education about the type of blood cancer, emotional and financial support, and routine monitoring. Fortunately, various resources are available for patients living with blood cancer. Read more.
|
|